251 related articles for article (PubMed ID: 7407756)
21. [A study of the use of sequential chemotherapy in 176 cases of glioblastoma (author's transl)].
Buge A; Poisson M; Pouillart P
Rev Neurol (Paris); 1978 May; 134(5):369-77. PubMed ID: 364592
[TBL] [Abstract][Full Text] [Related]
22. Combination chemotherapy with VM 26 and CCNU in primary malignant brain tumors of children.
Seiler RW
Helv Paediatr Acta; 1980 Mar; 35(1):51-6. PubMed ID: 7410103
[TBL] [Abstract][Full Text] [Related]
23. [Letter: Chemotherapy of operated malignant brain gliomas using a combination of VM 26 and CCNU].
Paillas JE; Pellet W; Pollet JF; D'Estienne d'Orves JF
Nouv Presse Med; 1976 Feb; 5(7):433-4. PubMed ID: 768919
[No Abstract] [Full Text] [Related]
24. [Chemotherapy of malignant glioma. Results of studies of the EORTC group of brain tumors].
Hildebrand JG
Rev Neurol (Paris); 1992; 148(6-7):435-40. PubMed ID: 1448663
[TBL] [Abstract][Full Text] [Related]
25. [Chemo-radiotherapy for malignant brain tumors].
Kochi M; Ushio Y
Gan To Kagaku Ryoho; 2002 May; 29(5):669-76. PubMed ID: 12040669
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy. A Phase II study.
Brandes AA; Tosoni A; Vastola F; Pasetto LM; Coria B; Danieli D; Iuzzolino P; Gardiman M; Talacchi A; Ermani M
Cancer; 2004 Nov; 101(9):2079-85. PubMed ID: 15372474
[TBL] [Abstract][Full Text] [Related]
27. A review of studies of the EORTC brain tumor group.
Hildebrand J
Cancer Treat Rep; 1981; 65 Suppl 2():89-94. PubMed ID: 7049364
[TBL] [Abstract][Full Text] [Related]
28. CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma.
Poplin EA; Aisner J; Van Echo DA; Whitacre M; Wiernik PH
Cancer Treat Rep; 1982 Jul; 66(7):1557-9. PubMed ID: 6284360
[TBL] [Abstract][Full Text] [Related]
29. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.
Levin VA; Wara WM; Davis RL; Vestnys P; Resser KJ; Yatsko K; Nutik S; Gutin PH; Wilson CB
J Neurosurg; 1985 Aug; 63(2):218-23. PubMed ID: 2991486
[TBL] [Abstract][Full Text] [Related]
30. Combination chemotherapy with VM 26 and CCNU in primary malignant brain tumors.
Seiler RW; Vassella F; Markwalder H
Surg Neurol; 1979 Mar; 11(3):237-42. PubMed ID: 473022
[TBL] [Abstract][Full Text] [Related]
31. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
Kesari S; Schiff D; Doherty L; Gigas DC; Batchelor TT; Muzikansky A; O'Neill A; Drappatz J; Chen-Plotkin AS; Ramakrishna N; Weiss SE; Levy B; Bradshaw J; Kracher J; Laforme A; Black PM; Folkman J; Kieran M; Wen PY
Neuro Oncol; 2007 Jul; 9(3):354-63. PubMed ID: 17452651
[TBL] [Abstract][Full Text] [Related]
32. Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid.
Yung WK; Kyritsis AP; Gleason MJ; Levin VA
Clin Cancer Res; 1996 Dec; 2(12):1931-5. PubMed ID: 9816151
[TBL] [Abstract][Full Text] [Related]
33. Practical guidelines for the treatment of malignant gliomas.
Chamberlain MC; Kormanik PA
West J Med; 1998 Feb; 168(2):114-20. PubMed ID: 9499745
[TBL] [Abstract][Full Text] [Related]
34. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
Prados MD; Seiferheld W; Sandler HM; Buckner JC; Phillips T; Schultz C; Urtasun R; Davis R; Gutin P; Cascino TL; Greenberg HS; Curran WJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1147-52. PubMed ID: 15001257
[TBL] [Abstract][Full Text] [Related]
35. Advantage of post-radiotherapy chemotherapy with CCNU, procarbazine, and vincristine (mPCV) over chemotherapy with VM-26 and CCNU for malignant gliomas.
Jeremic B; Jovanovic D; Djuric LJ; Jevremovic S; Mijatovic LJ
J Chemother; 1992 Apr; 4(2):123-6. PubMed ID: 1321239
[TBL] [Abstract][Full Text] [Related]
36. One year of procarbazine lomustine and vincristine is poorly tolerated in low grade glioma: a real world experience in a national neuro-oncology centre.
Keogh RJ; Aslam R; Hennessy MA; Coyne Z; Hennessy BT; Breathnach OS; Grogan L; Morris PG
BMC Cancer; 2021 Feb; 21(1):140. PubMed ID: 33557783
[TBL] [Abstract][Full Text] [Related]
37. Procarbazine, vincristine, CCNU, and cyclophosphamide (POCC) in the treatment of metastatic malignant melanoma.
Green MR; Dillman RO; Horton C
Cancer Treat Rep; 1980 Jan; 64(1):139-42. PubMed ID: 7379047
[TBL] [Abstract][Full Text] [Related]
38. Dose-intensive, time-compressed procarbazine, CCNU, vincristine (PCV) with peripheral blood stem cell support and concurrent radiation in patients with newly diagnosed high-grade gliomas.
Jakacki RI; Siffert J; Jamison C; Velasquez L; Allen JC
J Neurooncol; 1999 Aug; 44(1):77-83. PubMed ID: 10582673
[TBL] [Abstract][Full Text] [Related]
39. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.
Levin VA; Silver P; Hannigan J; Wara WM; Gutin PH; Davis RL; Wilson CB
Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):321-4. PubMed ID: 2154418
[TBL] [Abstract][Full Text] [Related]
40. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
